TB500 (Thymosin Beta-4) – 10mg

$100.00

10mg – Lyophilized *MUST BE RECONSTITUTED FOR RESEARCH APPLICATIONS*

TB-500 10mg (Thymosin Beta-4) is an advanced, high-purity synthetic 43-amino-acid peptide engineered to study rapid cell migration, angiogenesis, and structural tissue remodeling cascades. By binding tightly to G-actin to drive endothelial cell motility and upregulating vascular endothelial growth factor (VEGF) signaling, this precisely standardized 10mg presentation stands as a premier investigative tool for tracking accelerated fibroblast collagen synthesis, musculoskeletal repair, and soft tissue wound healing in laboratory models.

Supplied as a stable, premium-grade lyophilized powder in a single 10mg vial. Restricted strictly to laboratory and in vitro evaluation.

Description

Eterna Peptides presents premium-grade TB-500 (10mg) lyophilized powder, a highly purified synthetic peptide representing the primary active domain of endogenous Thymosin Beta-4 ($T\beta\text{-}4$). Composed of a 43-amino-acid sequence, TB-500 is a major actin-sequestering molecule found in high concentrations within cellular cytoplasm and wound fluid matrices. Extensively investigated across regenerative medicine, orthopedics, and wound healing biology, this precise 10mg single-vial format serves as a premier investigative tool for tracking advanced cellular migration kinetics, rapid angiogenesis, and musculoskeletal tissue remodeling.

### Mechanism of Action
TB-500 functions as a versatile pleiotropic regulator of cellular architecture and tissue repair pathways:
* **Actin Polymerization & G-Actin Binding:** TB-500 binds with high affinity to monomeric G-actin, acting as a primary intracellular actin-sequestering peptide. This binding controls actin polymerization dynamics, directly driving the physical motility, migration, and structural positioning of healing cells toward damaged tissue boundaries.
* **Upregulation of Angiogenesis (VEGF Signaling):** In vascular endothelium models, TB-500 stimulates the expression of Vascular Endothelial Growth Factor ($VEGF$). This signaling cascade promotes endothelial cell proliferation, migration, and the morphogenesis of new capillary networks, restoring microvascular perfusion to ischemic matrices.
* **Fibroblast Proliferation & Collagen Alignment:** Under physical trauma simulation, TB-500 modulates dermal fibroblast layout and upregulates Type I collagen transcription. It is actively monitored for its capacity to organize collagen cross-linking, optimizing structural tensile strength while mitigating disorganized, restrictive scar tissue formation.
* **Matrix Metalloproteinase (MMP) Modulation:** The peptide regulates the localized expression of matrix metalloproteinases, the enzymes responsible for breaking down the extracellular matrix to clear out cellular debris and make way for fresh tissue remodeling.

### Research Applications
In preclinical and in vitro laboratory models, TB-500 10mg vials are actively utilized to investigate:
* High-velocity soft tissue wound healing, dermal re-epithelialization, and hair follicle progenitor cell activation.
* Musculoskeletal recovery kinetics, satellite cell proliferation, and the repair of structural ligaments, tendons, and myofibrillar matrices.
* Endothelial cell migration, capillary tube formation, and systemic microvascular branching networks.
* Anti-inflammatory signaling profiles, macrophage phenotype shifts, and neuroprotective/cardiac tissue recovery mechanics.

Our TB-500 vials undergo strict laboratory stabilization, purification, and uniform vacuum-drying guidelines to ensure absolute peptide chain integrity, rapid reconstitution kinetics, and dependable experimental reproducibility.


*Disclaimer: This product is sold strictly for laboratory research and development use only. It is not intended for human consumption, diagnostic, or therapeutic purposes.*

Menu

Research Categories